Press "Enter" to skip to content

New patent for Glaxosmithkline Llc drug LAMICTAL ODT

0
Copyright © DrugPatentWatch. Originally published at New patent for Glaxosmithkline Llc drug LAMICTAL ODT

Annual Drug Patent Expirations for LAMICTAL+ODT
Annual Drug Patent Expirations for LAMICTAL+ODT

Lamictal Odt is a drug marketed by Glaxosmithkline Llc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.

LAMICTAL ODT drug price trends.

Drug patent litigation for LAMICTAL ODT.

This drug has eighteen patent family members in thirteen countries.

The generic ingredient in LAMICTAL ODT is lamotrigine. One supplier is listed for this compound. Additional details are available on the lamotrigine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Glaxosmithkline Llc drug LAMICTAL ODT
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions